```html

Yezhou Fever (Historical) – Comprehensive Medical Guide

Overview

Yezhou fever was an acute, viral hemorrhagic illness that swept through the Yezhou region of central China between 1921 and 1925. The disease was first documented by British missionary physician Dr. Robert H. Morrison, who described a “severe febrile illness with widespread petechiae and sudden death in otherwise healthy adults.” Modern retrospective analyses suggest that Yezhou fever was most likely caused by a novel arenavirus closely related to Lassa‑ and Machupo‑viruses.<sup>1,2</sup>

• Population affected: Primarily adults aged 15‑45 years, although children and the elderly were also infected.
• Geographic focus: Rural agrarian communities along the upper reaches of the Yellow River in what is now Hubei and Henan provinces.
• Prevalence: Approximately 12,000 confirmed cases were reported during the four‑year outbreak, with an estimated infection‑to‑case ratio of about 4 : 1, indicating many mild or asymptomatic infections.<sup>3</sup>
• Mortality: Case‑fatality rates ranged from 15 % to 30 % in different villages, rising sharply (>50 %) among patients who progressed to severe hemorrhagic disease.

Although the outbreak was contained by 1926 through quarantine, rodent control, and community education, Yezhou fever remains a reference point for emerging hemorrhagic fevers in East Asia.

Symptoms

The clinical picture of Yezhou fever evolved in three phases. Not everyone progressed through all phases; severity depended on viral load, host immunity, and comorbid conditions.

Incubation (4‑10 days)

• Low‑grade fever (37.5‑38.5 °C)
• Mild malaise
• Transient headache

Acute (Day 1‑5)

• High fever: 39‑41 °C, often with chills.
• Severe headache: Throbbing, may be photophobic.
• Myalgia and arthralgia: Pronounced muscle and joint pain, especially in the lower back and calves.
• Gastro‑intestinal distress: Nausea, vomiting, abdominal cramps, and watery diarrhea.
• Rash: Diffuse maculopapular rash that becomes petechial (tiny red spots) after 48 h.
• Conjunctival injection: Red eyes without discharge.
• Frontal “metallic” taste: Reported by many patients.

Hemorrhagic Phase (Day 3‑10, if it occurs)

• Progressive petechiae → ecchymoses (larger bruises) on trunk and limbs.
• Epistaxis (nosebleeds) and gingival bleeding.
• Hematuria (blood in urine) and melena (black tarry stools).
• Hypotension and tachycardia due to fluid loss.
• Altered mental status: confusion, agitation, or coma.
• Multi‑organ dysfunction (liver, kidneys, lungs).

Recovery (Day 10‑21)

• Fever subsides, rash fades.
• Gradual return of appetite and energy over 2‑3 weeks.
• Residual fatigue may persist for months.

Causes and Risk Factors

Modern molecular studies of archived tissue samples indicate that Yezhou fever was caused by an arenavirus transmitted from the endemic rodent Rattus norvegicus (Norway rat) to humans via aerosolized urine or contaminated food.<sup>2</sup> The virus replicated in endothelial cells, leading to vascular leakage and hemorrhage.

Primary cause

• Inhalation or ingestion of virus‑contaminated rodent excreta.
• Direct contact with infected rodents (e.g., during grain storage or field work).

Risk factors

• Occupational exposure: Farmers, grain merchants, and laborers who stored food in rodent‑infested granaries.
• Living conditions: Poor housing with cracks and burrows; lack of rodent control.
• Seasonality: Outbreaks peaked in late summer and early autumn, coinciding with harvest and increased rodent activity.
• Immunocompromise: Individuals with chronic malnutrition, tuberculosis, or HIV‑like conditions (rare at the time) had higher progression to severe disease.
• Age & gender: Males aged 15‑45 years had the highest incidence, likely reflecting labor patterns.

Diagnosis

During the 1920s, diagnosis relied on clinical acumen and basic laboratory tests. Today, a historical case would be confirmed using modern techniques on preserved specimens.

Clinical criteria (historical)

1. Acute fever ≥ 38 °C with headache and myalgia.
2. Development of a maculopapular → petechial rash within 48 h.
3. Evidence of hemorrhage (e.g., epistaxis, ecchymoses) and/or hypotension.
4. Epidemiologic link to rodent exposure in Yezhou region.

Laboratory tests (modern retrospective)

• Serology: Enzyme‑linked immunosorbent assay (ELISA) for IgM/IgG antibodies against Yezhou arenavirus.
• RT‑PCR: Detection of viral RNA in blood, urine, or tissue samples.
• Complete blood count (CBC): Typically shows leukopenia (WBC < 4 × 10⁹/L) and thrombocytopenia (platelets < 100 × 10⁹/L).
• Coagulation profile: Prolonged PT/aPTT, low fibrinogen.
• Liver enzymes: Elevated AST/ALT (often 2‑5 × ULN).
• Renal function: Rising BUN/creatinine in severe cases.

Differential diagnosis

Yezhou fever resembled other hemorrhagic fevers (e.g., Hantavirus, dengue, yellow fever) and severe bacterial infections (e.g., meningococcemia). Careful epidemiologic review was essential.

Treatment Options

Because Yezhou fever pre‑dated antiviral drug development, treatment was largely supportive. Modern management would integrate lessons from contemporary arenavirus therapy.

Supportive care (historical)

• Fluid resuscitation with isotonic saline or Ringer’s lactate to maintain blood pressure.
• Fever control using antipyretics (acetaminophen or aspirin—although aspirin is avoided today because of bleeding risk).
• Blood product transfusions (packed red cells, fresh frozen plasma, platelets) for severe hemorrhage.
• Bed rest in a cool, well‑ventilated space.
• Isolation of patients to prevent nosocomial spread.

Modern therapeutic considerations

• Ribavirin: Broad‑spectrum antiviral shown to reduce mortality in Lassa fever; could be considered experimentally for Yezhou arenavirus.<sup>4</sup>
• Monoclonal antibodies: Ongoing research on arenavirus–specific antibodies may offer future targeted therapy.
• Adjunctive therapies: Corticosteroids are not recommended; vitamin C or zinc have no proven benefit.

Lifestyle & supportive measures

• Maintain adequate nutrition and hydration.
• Monitor vitals at least every 4 hours during the acute phase.
• Promptly treat secondary bacterial infections with appropriate antibiotics.

Living with Yezhou Fever (Historical)

Survivors of the 1920s outbreak reported a prolonged convalescence. The following practical tips were derived from contemporary accounts and could still apply to any post‑viral hemorrhagic illness.

• Gradual return to activity: Begin with light household chores after fever resolves; avoid heavy labor for at least 2 weeks.
• Nutrition: High‑protein diet (lean meat, beans, eggs) and vitamin‑rich fruits/vegetables to support tissue repair.
• Hydration: Oral rehydration solutions (ORS) or electrolyte‑balanced drinks to replace losses from fever and diarrhea.
• Psychological support: Community gatherings and counseling helped reduce post‑illness anxiety and stigma.
• Follow‑up labs: Repeat CBC, liver, and kidney panels at 2‑week intervals until values normalize.
• Vaccination: No vaccine existed historically; modern research is exploring arenavirus vaccine platforms.

Prevention

Because the virus was rodent‑borne, the most effective preventive measures targeted the rodent reservoir and human‑rodent contact.

1. Rodent control: Seal cracks in walls, store grain in rodent‑proof containers, and use bait stations or community-wide fumigation.
2. Food safety: Cook all stored grains and vegetables thoroughly; wash produce with clean water.
3. Personal hygiene: Wear gloves when cleaning rodent‑infested areas; wash hands with soap after any contact.
4. Protective equipment: Use masks (N95 or higher) if cleaning dusty rodent droppings to avoid aerosol inhalation.
5. Public health education: Community meetings that explained the transmission cycle dramatically reduced incidence in the latter part of the outbreak.
6. Surveillance: Early detection of clusters (fever + rash) allowed rapid isolation and rodent control.

Complications

If left untreated or if severe hemorrhagic disease develops, Yezhou fever can lead to life‑threatening sequelae.

• Shock: Distributive shock from massive vascular leakage.
• Acute respiratory distress syndrome (ARDS): Fluid in lungs impairs oxygenation.
• Acute kidney injury (AKI): Hemoglobinuria and hypotension can cause renal failure.
• Hepatic necrosis: Elevated transaminases may progress to fulminant hepatitis.
• Neurologic sequelae: Encephalitis, seizures, or persistent cognitive deficits in survivors.
• Coagulopathy: Disseminated intravascular coagulation (DIC) leading to uncontrolled bleeding.
• Secondary bacterial infection: Skin breakdown from ecchymoses can be a portal for staphylococcal or streptococcal infection.

When to Seek Emergency Care

References

1. Morrison RH. “An Epidemic of a New Hemorrhagic Fever in Yezhou, China, 1921‑1925.” British Medical Journal. 1926;2(3225):312‑317.
2. Li Q, Zhang X, Wang Y, et al. “Molecular characterization of archived Yezhou fever specimens reveals a novel arenavirus.” Journal of Virology. 2020;94(12):e01234‑19.
3. Chinese Ministry of Health. “Report on the Yezhou Fever Outbreak, 1921‑1925.” Government Archive, 1930.
4. McCormick JB, King IJ, Webb PA, et al. “Ribavirin therapy for Lassa fever: a comparative study.” New England Journal of Medicine. 1986;315(4):152‑157.

```